Silence Therapeutics (SLN) Short-Term Debt repayments: 2020-2024
Historic Short-Term Debt repayments for Silence Therapeutics (SLN) over the last 3 years, with Sep 2024 value amounting to -$63,666.
- Silence Therapeutics' Short-Term Debt repayments fell 2.57% to -$63,666 in Q3 2024 from the same period last year, while for Sep 2024 it was -$226,624, marking a year-over-year decrease of 25.46%. This contributed to the annual value of -$516,227 for FY2020, which is N/A change from last year.
- According to the latest figures from Q3 2024, Silence Therapeutics' Short-Term Debt repayments is -$63,666, which was down 2.57% from -$62,068 recorded in Q3 2023.
- Silence Therapeutics' Short-Term Debt repayments' 5-year high stood at $559,705 during Q3 2021, with a 5-year trough of -$701,660 in Q2 2021.
- Its 3-year average for Short-Term Debt repayments is -$52,905, with a median of -$62,068 in 2023.
- In the last 5 years, Silence Therapeutics' Short-Term Debt repayments spiked by 91.03% in 2022 and then tumbled by 251.10% in 2023.
- Over the past 5 years, Silence Therapeutics' Short-Term Debt repayments (Quarterly) stood at -$171,659 in 2020, then reached $559,705 in 2021, then crashed by 103.16% to -$17,678 in 2022, then plummeted by 251.10% to -$62,068 in 2023, then fell by 2.57% to -$63,666 in 2024.
- Its Short-Term Debt repayments was -$63,666 in Q3 2024, compared to -$62,068 in Q3 2023 and -$42,546 in Q2 2023.